These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 23949904)
1. Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathways. Chen YY; Lu HF; Hsu SC; Kuo CL; Chang SJ; Lin JJ; Wu PP; Liu JY; Lee CH; Chung JG; Chang JB Environ Toxicol; 2015 Jan; 30(1):74-82. PubMed ID: 23949904 [TBL] [Abstract][Full Text] [Related]
2. Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways. Wu SH; Hsiao YT; Kuo CL; Yu FS; Hsu SC; Wu PP; Chen JC; Hsia TC; Liu HC; Hsu WH; Chung JG Am J Chin Med; 2015; 43(6):1247-64. PubMed ID: 26446205 [TBL] [Abstract][Full Text] [Related]
3. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways. Chueh FS; Chen YY; Huang AC; Ho HC; Liao CL; Yang JS; Kuo CL; Chung JG Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632 [TBL] [Abstract][Full Text] [Related]
4. Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells. Qiu DZ; Zhang ZJ; Wu WZ; Yang YK BMC Complement Altern Med; 2013 Jul; 13():185. PubMed ID: 23870199 [TBL] [Abstract][Full Text] [Related]
5. Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro. Huang AC; Yang MD; Hsiao YT; Lin TS; Ma YS; Peng SF; Hsia TC; Cheng YD; Kuo CL; Chung JG J Ethnopharmacol; 2016 Dec; 194():1043-1050. PubMed ID: 27833027 [TBL] [Abstract][Full Text] [Related]
6. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways. Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742 [TBL] [Abstract][Full Text] [Related]
7. Effects of laver extracts on adhesion, invasion, and migration in SK-Hep1 human hepatoma cancer cells. Do Thi N; Hwang ES Biosci Biotechnol Biochem; 2014; 78(6):1044-51. PubMed ID: 25036133 [TBL] [Abstract][Full Text] [Related]
8. 4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways. Yu FS; Lin ML; Hsu SC; Yu CC; Huang YP; Kuo YH; Chung JG Int J Oncol; 2016 Aug; 49(2):579-88. PubMed ID: 27221634 [TBL] [Abstract][Full Text] [Related]
9. Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin. Sheng X; Zhu P; Zhao Y; Zhang J; Li H; Zhao H; Qin J Recent Pat Anticancer Drug Discov; 2021; 16(1):54-65. PubMed ID: 33530915 [TBL] [Abstract][Full Text] [Related]
10. Phenylethyl isothiocyanate and its N-acetylcysteine conjugate suppress the metastasis of SK-Hep1 human hepatoma cells. Hwang ES; Lee HJ J Nutr Biochem; 2006 Dec; 17(12):837-46. PubMed ID: 16563723 [TBL] [Abstract][Full Text] [Related]
11. Sinulariolide Suppresses Human Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 through MAPKs and PI3K/Akt Signaling Pathways. Wu YJ; Neoh CA; Tsao CY; Su JH; Li HH Int J Mol Sci; 2015 Jul; 16(7):16469-82. PubMed ID: 26204832 [TBL] [Abstract][Full Text] [Related]
12. Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogen-activated protein kinase in SK-Hep1 human hepatoma cells. Hwang ES; Lee HJ Food Chem Toxicol; 2008 Jul; 46(7):2358-64. PubMed ID: 18502015 [TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
14. Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9. Kuo CL; Lai KC; Ma YS; Weng SW; Lin JP; Chung JG Oncol Rep; 2014 Jul; 32(1):355-61. PubMed ID: 24859325 [TBL] [Abstract][Full Text] [Related]
15. Tianeptine sodium salt suppresses TNF-α-induced expression of matrix metalloproteinase-9 in human carcinoma cells via suppression of the PI3K/Akt-mediated NF-κB pathway. Jayasooriya RG; Dilshara MG; Choi YH; Moon SK; Kim WJ; Kim GY Environ Toxicol Pharmacol; 2014 Sep; 38(2):502-9. PubMed ID: 25168152 [TBL] [Abstract][Full Text] [Related]
16. Antimetastatic effects of gambogic acid are mediated via the actin cytoskeleton and NF-κB pathways in SK-HEP1 cells. Park MS; Kim NH; Kang CW; Oh CW; Kim GD Drug Dev Res; 2015 May; 76(3):132-42. PubMed ID: 25959042 [TBL] [Abstract][Full Text] [Related]
17. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways. Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819 [TBL] [Abstract][Full Text] [Related]
18. Hispolon suppresses SK-Hep1 human hepatoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen activator through the PI3K/Akt and ERK signaling pathways. Huang GJ; Yang CM; Chang YS; Amagaya S; Wang HC; Hou WC; Huang SS; Hu ML J Agric Food Chem; 2010 Sep; 58(17):9468-75. PubMed ID: 20698552 [TBL] [Abstract][Full Text] [Related]
19. Bufalin inhibits cell proliferation and migration of hepatocellular carcinoma cells via APOBEC3F induced intestinal immune network for IgA production signaling pathway. Yang Z; Tao Y; Xu X; Cai F; Yu Y; Ma L Biochem Biophys Res Commun; 2018 Sep; 503(3):2124-2131. PubMed ID: 30100060 [TBL] [Abstract][Full Text] [Related]
20. Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions. Hong SH; Kim GY; Chang YC; Moon SK; Kim WJ; Choi YH Int J Oncol; 2013 Jan; 42(1):277-86. PubMed ID: 23128598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]